These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 37592723)
1. Emerging pharmacological strategies for treating and preventing mpox. Grosenbach DW; Russo AT; Blum ED; Hruby DE Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723 [TBL] [Abstract][Full Text] [Related]
2. Treatment and Vaccination for Smallpox and Monkeypox. Saalbach KP Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf. De Clercq E; Jiang Y; Li G Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis. Shamim MA; Satapathy P; Padhi BK; Veeramachaneni SD; Akhtar N; Pradhan A; Agrawal A; Dwivedi P; Mohanty A; Pradhan KB; Kabir R; Rabaan AA; Alotaibi J; Al Ismail ZA; Alsoliabi ZA; Al Fraij A; Sah R; Rodriguez-Morales AJ Front Pharmacol; 2023; 14():1149909. PubMed ID: 37214444 [TBL] [Abstract][Full Text] [Related]
5. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023. Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595 [TBL] [Abstract][Full Text] [Related]
6. Clinical considerations on monkeypox antiviral medications: An overview. Pourkarim F; Entezari-Maleki T Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674 [TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic targets for Mpox: the evidence to date. Byrareddy SN; Sharma K; Sachdev S; Reddy AS; Acharya A; Klaustermeier KM; Lorson CL; Singh K Expert Opin Ther Targets; 2023; 27(6):419-431. PubMed ID: 37368464 [TBL] [Abstract][Full Text] [Related]
8. A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus. Chenchula S; Ghanta MK; Amerneni KC; Rajakarunakaran P; Chandra MB; Chavan M; Gupta R Arch Virol; 2023 Jun; 168(7):195. PubMed ID: 37386209 [TBL] [Abstract][Full Text] [Related]
9. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential. Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515 [TBL] [Abstract][Full Text] [Related]
10. Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates. Prévost J; Sloan A; Deschambault Y; Tailor N; Tierney K; Azaransky K; Kammanadiminti S; Barker D; Kodihalli S; Safronetz D Antiviral Res; 2024 Nov; 231():105995. PubMed ID: 39243894 [TBL] [Abstract][Full Text] [Related]
11. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge. Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948 [TBL] [Abstract][Full Text] [Related]
12. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer? Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577 [TBL] [Abstract][Full Text] [Related]
13. Mpox (monkeypox): Diagnosis, prevention, and management in adults. Jarrell L; Perryman K Nurse Pract; 2023 Apr; 48(4):13-20. PubMed ID: 36975744 [TBL] [Abstract][Full Text] [Related]
14. Repurposing of the antibiotic nitroxoline for the treatment of mpox. Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic agents for the treatment of human mpox. Braddick M; Singh KP Curr Opin Infect Dis; 2024 Dec; 37(6):518-525. PubMed ID: 39382085 [TBL] [Abstract][Full Text] [Related]
17. Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult. Dammann F; Raja M; Camargo JF Transpl Infect Dis; 2023 Feb; 25(1):e14022. PubMed ID: 36714983 [TBL] [Abstract][Full Text] [Related]
18. Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review. Bruno G; Buccoliero GB Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895350 [TBL] [Abstract][Full Text] [Related]
19. Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements. Rani I; Joshi H; Sharma U; Kaur J; Sood S; Ramniwas S; Chauhan A; Abdulabbas HS; Tuli HS Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2055-2065. PubMed ID: 37837475 [TBL] [Abstract][Full Text] [Related]
20. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report. Martinez AE; Frattaroli P; Vu CA; Paniagua L; Mintz J; Bravo-Gonzalez A; Zamudio P; Barco A; Rampersad A; Lichtenberger P; Gonzales-Zamora JA Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]